<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> protein, WT1, represses transcription from several growth factor genes </plain></SENT>
<SENT sid="1" pm="."><plain>WT1 transcription is regulated in erythroid and myeloid lineages by the transcription factor GATA-1 </plain></SENT>
<SENT sid="2" pm="."><plain>Using a sensitive, isotopic duplex RT-PCR procedure amplifying WT1 or GATA-1 together with beta-actin as the internal control in a single reaction mix, we quantitated the expression of WT1 and GATA-1 mRNA of 16 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 56 with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and 22 with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) </plain></SENT>
<SENT sid="3" pm="."><plain>K562 was used as reference positive control for this cell line expresses both WT1 and GATA-1 </plain></SENT>
<SENT sid="4" pm="."><plain>Among <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, increased WT1 expression was found in <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blast (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>) subtypes compared to the <z:mpath ids='MPATH_458'>normal</z:mpath> controls, whereas WT1 expression in <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) was not different from the <z:mpath ids='MPATH_458'>normal</z:mpath> control level </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cases of subtypes M0, M1, M2 and M3 expressed WT1 more than three times the <z:mpath ids='MPATH_458'>normal</z:mpath> WT1 level </plain></SENT>
<SENT sid="6" pm="."><plain>Subtypes M4 to M7 showed significantly lower WT1 levels than M1 to M3 and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cases with CD14+ expressed less WT1 than CD14- </plain></SENT>
<SENT sid="7" pm="."><plain>Higher than <z:mpath ids='MPATH_458'>normal</z:mpath> WT1 levels were also expressed in cases of ALL </plain></SENT>
</text></document>